LBRX
LB Pharmaceuticals Inc Common Stock
NASDAQ: LBRX · HEALTHCARE · BIOTECHNOLOGY
$31.71
+3.66% today
Updated 2026-04-30
Market cap
$912.17M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.13
Dividend yield
—
52W range
$13 – $33
Volume
0.3M
LB Pharmaceuticals Inc Common Stock (LBRX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-2.73M | $-12.09M | $-53.05M | $-35.21M |
| Capital expenditures | $0.00 | $25000.00 | $769000.00 | $52000.00 |
| Depreciation | — | — | — | — |
| Stock-based comp | $431000.00 | $295000.00 | $3.16M | $4.19M |
| Free cash flow | $-2.73M | $-12.12M | $-53.82M | $-35.26M |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |